Literature DB >> 23618122

Exposure-based traffic crash injury rates by mode of travel in British Columbia.

Kay Teschke1, M Anne Harris, Conor C O Reynolds, Hui Shen, Peter A Cripton, Meghan Winters.   

Abstract

BACKGROUND: Traffic-related trauma is an important contributor to morbidity and mortality in Canada, especially among children and young adults. Comparing exposure-based injury rates between travel modes and jurisdictions is a valuable tool towards improving safety.
METHODS: We used injury data from the British Columbia Motor Vehicle Branch, trip diary data from the Metro Vancouver transportation authority, and population and provincial travel data from the Census to calculate crude fatality and injury rates for motor vehicle occupants, bicyclists, and pedestrians. We used three different denominators: population; person-trip; and distance travelled.
RESULTS: Motor vehicle occupants had the lowest fatality rates using exposure-based denominators: 9.6 per 100 million person-trips and 0.97 per 100 million km. Bicyclists and pedestrians had similar fatality rates using one denominator (13.8 vs. 14.7 per 100 million person-trips, respectively), but bicyclists had a lower rate using the other (2.60 vs. 7.37 per 100 million km). For injuries, pedestrians had the lowest rate and bicyclists the highest using the person-trip denominator, whereas motor vehicle occupants had the lowest rate using the distance denominator, and bicycling and walking had similar rates.
CONCLUSIONS: Risks of driving, walking and bicycling in British Columbia were similar to their risks in the United States. The injury and fatality rates for these three travel modes were intermediate compared to much higher rates among US motorcyclists and much lower rates among US bus passengers. Data improvements would enable transportation trauma rate calculations for Canada as a whole and for other modes of travel (transit, motorcycling).

Entities:  

Keywords:  Traffic accidents; active transportation; automobile driving; bicycling; walking

Mesh:

Year:  2013        PMID: 23618122

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  7 in total

1.  Bringing health into transportation and land use scenario planning: Creating a National Public Health Assessment Model (N-PHAM).

Authors:  Jessica Schoner; Jim Chapman; Eric H Fox; Nicole Iroz-Elardo; Allen Brookes; Kara E MacLeod; Lawrence D Frank
Journal:  J Transp Health       Date:  2018-09

2.  School transportation mode, by distance between home and school, United States, ConsumerStyles 2012.

Authors:  Laurie F Beck; Daniel D Nguyen
Journal:  J Safety Res       Date:  2017-04-19

3.  Severity of urban cycling injuries and the relationship with personal, trip, route and crash characteristics: analyses using four severity metrics.

Authors:  Peter A Cripton; Hui Shen; Jeff R Brubacher; Mary Chipman; Steven M Friedman; M Anne Harris; Meghan Winters; Conor C O Reynolds; Michael D Cusimano; Shelina Babul; Kay Teschke
Journal:  BMJ Open       Date:  2015-01-05       Impact factor: 2.692

4.  An economic analysis of the health-related benefits associated with bicycle infrastructure investment in three Canadian cities.

Authors:  David G T Whitehurst; Danielle N DeVries; Daniel Fuller; Meghan Winters
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

5.  A Spatial Autoregressive Quantile Regression to Examine Quantile Effects of Regional Factors on Crash Rates.

Authors:  Tianjian Yu; Fan Gao; Xinyuan Liu; Jinjun Tang
Journal:  Sensors (Basel)       Date:  2021-12-21       Impact factor: 3.576

6.  Bicycling injury hospitalisation rates in Canadian jurisdictions: analyses examining associations with helmet legislation and mode share.

Authors:  Kay Teschke; Mieke Koehoorn; Hui Shen; Jessica Dennis
Journal:  BMJ Open       Date:  2015-11-02       Impact factor: 2.692

7.  The epidemiology of fatal cyclist crashes over a 14-year period in Alberta, Canada.

Authors:  Lindsay Gaudet; Nicole T R Romanow; Alberto Nettel-Aguirre; Donald Voaklander; Brent E Hagel; Brian H Rowe
Journal:  BMC Public Health       Date:  2015-11-17       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.